Yake Biotechnology Ltd. Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2018
NCT04283006
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai YaKe Biotechnology Ltd. | Yake Biotechnology Ltd.